[1]LIU CH,LIU P,HU YY,et al.Progress of clinical and basic research on liver fibrosis with Traditional Chinese Medicine[J].World Sci Technol Modern Tradit Chin Med,2007,9(2):112-119.(in Chinese)刘成海,刘平,胡义扬,等.中医药抗肝纤维化临床与基础研究进展[J].世界科学技术-中医药现代化,2007,9(2):112-119.
|
[2]LIU C,HU Y,XU L,et al.Effect of Fuzheng Huayu formula and its actions against liver fibrosis[J].Chin Med,2009,4:12-22.
|
[3]HASSANEIN T,BOX T,TONG M.A phase II,randomized,placebo-controlled,double-blind,multicenter study to assess the antifibrotic activity of Fuzheng Huayu in chronic hepatitis C patients with hepatic fibrosis[C]//.23th Conference of the Asian Pacifc Association for the Study of the Liver.Australia:Gastroenterological Sociaty of Australia,2014:308-309.
|
[4]WANG QL,TAO YY,SHEN L,et al.Chinese herbal medicine Fuzheng Huayu recipe inhibits liver fibrosis by mediating the transforming growth factor-β1/Smads signaling pathway[J].J Chin Integr Med,2012,10(5):561-568.(in Chinese)王清兰,陶艳艳,沈丽,等.扶正化瘀方影响转化生长因子β1/Smad信号通路的抗肝纤维化作用机制[J].中西医结合学报,2012,10(5):561-568
|
[5]TAO YY,YAN XC,ZHOU T,et al.Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-alpha induced hepatocyte apoptosis[J].BMC Complement Altern Med,2014,14:449.
|
[6]ADLAKHA YK,SAINI N.Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128[J].Mol Cancer,2014,13:33.
|
[7]PENCHEVA N,TRAN H,BUSS C,et al.Convergent multimiRNA targeting of Apo E drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis[J].Cell,2012,151(5):1068-1082.
|
[8]XIN X,ZHANG Y,LIU X,et al.MicroRNA in hepatic fibrosis and cirrhosis[J].Front Biosci(Landmark Ed),2014,19:1418
|
[9]HUANG C,ZHENG JM,CHENG Q,et al.Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B virus infection[J].J Dig Dis,2014,15(11):614-621.
|
[10]HE Y,HUANG C,LIN X,et al.MicroRNA-29 family,a crucial therapeutic target for fibrosis diseases[J].Biochimie,2013,95(7):1355-1359.
|
[11]YANG D,GAO YH,TAN KB,et al.Inhibition of hepatic fibrosis with artificial microRNA using ultrasound and cationic liposomebearing microbubbles[J].Gene Ther,2013,20(12):1140-1148.
|
[12]WANG QL,LI JX,LYU J,et al.Functional analysis of differential microRNA expression profile in mouse fibrotic liver tissues induced by CCl4[J].Chin J Pathophysiol,2013,29(12):2201-2211.(in Chinese)王清兰,李俊霞,吕靖,等.CCl4诱导的小鼠纤维化肝组织微小RNA差异表达谱及初步功能分析[J].中国病理生理杂志,2013,29(12):2201-2211.
|
[13]TSUKAMOTO H,MATSUOKA M,FRENCH SW.Experimental models of hepatic fibrosis:a review[J].Semin Liver Dis,1990,10(1):56-65.
|
[14]JAMALL IS,FINELLI VN,QUE HEE SS.A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues[J].Anal Biochem,1981,112(1):70-75.
|
[15]HUANG DA W,SHERMAN BT,LEMPICKI RA.Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources[J].Nat Protoc,2009,4(1):44-57.
|
[16]LI XR,CHU HJ,LV T,et al.miR-342-3p suppresses proliferation,migration and invasion by targeting FOXM1 in human cervical cancer[J].FEBS Lett,2014,588(17):3298-3307.
|
[17]WANG L,XU L,XU M,et al.Obesity-associated miR-342-3p promotes adipogenesis of mesenchymal stem cells by suppressing Ct BP2and releasing C/EBPalpha from Ct BP2 binding[J].Cell Physiol Biochem,2015,35(6):2285-2298.
|
[18]CAO S,XIAO L,RAO JN,et al.Inhibition of Smurf2 translation by miR-322/503 modulates TGF-beta/Smad2 signaling and intestinal epithelial homeostasis[J].Mol Biol Cell,2014,25(8):1234-1243.
|
[19]QIN L,CHEN Y,NIU Y,et al.A deep investigation into the adipogenesis mechanism:profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway[J].BMC Genomics,2010,11:320.
|
[20]LLOBET-NAVAS D,RODRIGUEZ-BARRUECO R,de la IGLESIA-VICENTE J,et al.The microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor beta in mammary epithelial cells[J].Mol Cell Biol,2014,34(23):4216-4231.
|
[21]GHOSH G,SUBRAMANIAN IV,ADHIKARI N,et al.Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis[J].J Clin Invest,2010,120(11):4141-4154.
|
[22]WURDINGER T,TANNOUS BA,SAYDAM O,et al.miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells[J].Cancer Cell,2008,14(5):382-393.
|
[23]SAVI F,FORNO I,FAVERSANI A,et al.miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo[J].Clin Sci(Lond),2014,127(4):233-242.
|
[24]LYU J,LIU CH.Effect of Fuzheng Huayu prescription on angiogenesis in rats with fibrosis[C]∥.The 18th National Conference of Integrated Traditional Chinese and Western Medicine Therapy of Liver Disease.Shenzhen,2009.(in Chinese)吕靖,刘成海.扶正化瘀方对纤维化大鼠血管生成的影响[C]//.第十八次全国中西医结合肝病学术会议.深圳,2009.
|
[25]ASHBURNER M,BALL CA,BLAKE JA,et al.Gene ontology:tool for the unification of biology.The Gene Ontology Consortium[J].Nat Genet,2000,25(1):25-29.
|
[26]ELSHARKAWY AM,OAKLEY F,MANN DA.The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis[J].Apoptosis,2005,10(5):927-939.
|
[27]ABBAS G,SILVEIRA MG,LINDOR KD.Hepatic fibrosis and the renin-angiotensin system[J].Am J Ther,2010,18(6):e202-e208.
|
[28]KANEHISA M,GOTO S,KAWASHIMA S,et al.The KEGG resource for deciphering the genome[J].Nucleic Acids Res,2004,32(Database issue):d277-d280.
|
[29]SEKI E,de MINICIS S,OSTERREICHER CH,et al.TLR4 enhances TGF-beta signaling and hepatic fibrosis[J].Nat Med,2007,13(11):1324-1332.
|
[30]ALISI A,ARCIELLO M,PETRINI S,et al.Focal adhesion kinase(FAK)mediates the induction of pro-oncogenic and fibrogenic phenotypes in hepatitis C virus(HCV)-infected cells[J].PLo S One,2012,7(8):e44147.
|
[31]JI L,XUE R,TANG W,et al.Toll like receptor 2 knock-out attenuates carbon tetrachloride(CCl4)-induced liver fibrosis by downregulating MAPK and NF-kappa B signaling pathways[J].FEBS Lett,2014,588(12):2095-2100.
|
[32]CUI X,ZHANG X,YIN Q,et al.Factin cytoskeleton reorganization is associated with hepatic stellate cell activation[J].Mol Med Rep,2014,9(5):1641-1647.
|
[33]MIAO CG,YANG YY,HE X,et al.Wnt signaling in liver fibrosis:progress,challenges and potential directions[J].Biochimie,2013,95(12):2326-2335.
|
[34]MAIR M,BLAAS L,OSTERREICHER CH,et al.JAK-STAT signaling in hepatic fibrosis[J].Front Biosci(Landmark Ed),2011,16:2794-2811.
|